A Study Of Inotuzumab Ozogamicin Plus Rituximab For Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma Patients Who Are Not Candidates For Intensive High-Dose Chemotherapy

Clinical trial NCT01232556 · TERMINATED

Trial details

NCT number: NCT01232556
Sponsor: Pfizer
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Lymphoma, Non-Hodgkin

Start date: 2011-04-04
Primary completion: 2014-03-28
Enrollment: 338

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.